MedPath

Effect of aromatherapy and counseling based on mindfulness on sexual function, anxiety, and serum level of some bio-markers in postmenopausal wome

Phase 3
Conditions
Condition 1: Anxiety. Condition 2: Sexual dysfunction. Condition 3: Depression. Condition 4: Serum levels of some bio-markers. Condition 5: Menopausal symptoms. Condition 6: Sleep quality.
Other anxiety disorders
Sexual dysfunction not due to a substance or known physiological condition
Major depressive disorder, single episode
Menopausal and other perimenopausal disorders
Sleep disorders
Registration Number
IRCT20131009014957N8
Lead Sponsor
Tabriz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
132
Inclusion Criteria

Willingness to participate in the study
Postmenopausal women between the ages of 50-60
Having read and write literacy
The Female Sexual Function Score less than 28
Having mild to moderate anxiety based on Beck Anxiety Scale
Having sex in the family limit with her permanent spouse
Having only one wife for the man
Natural menopause
Obtaining a score of 15-42 on the Greene scale
Having a score of 5 and higher in The Pittsburgh Sleep Quality Index (PSQI)

Exclusion Criteria

Known physical and mental illnesses based on person's self statement (depression, diabetes, cardiovascular disease, olfactory sensations, mental disability, diabetes)
Drugs affecting sex (sildenafil, antidepressants, antihistamines, diazepines, barbiturates, amphetamines, antihypertensive drugs, cocaine, thiazide diuretics, narcotics
Use of herbal ingredients to increase sexual desire in men or women (ginseng, cinnamon, ginger, etc.) and alergy to any herbal medicine
Addiction to the habitual consumption of alcohol and tobacco by women
Participate in other similar studies
Occurrence of an misadventure within 3 months prior of study (death or acute illness of close relatives)
Disorder in the sense of smell according to person's self and other nasal disorders (fracture, aberration, rhinitis)
Use of hormotherapy at last 6 month

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Anxiety score in Beck Anxiety Inventory. Timepoint: At baseline and 8 weeks after intervention. Method of measurement: Beck Anxiety Inventory.;Sexual function score in Female Sexual Function Index. Timepoint: At baseline and 8 weeks after intervention. Method of measurement: Female Sexual Function Index.;Serum level of cortisol. Timepoint: At baseline and immediately after intervention. Method of measurement: Elisa method by ELISA kits.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath